Pj. Van Enckevort et al., Factors to consider when designing phase III clinical trials involving economic evaluations, PERC MOT SK, 89(3), 1999, pp. 1059-1072
Given the recognized need to examine cost-effectiveness data in addition to
clinical data when making decisions relating to choice of clinical interve
ntions, there is a growing interest and experience in undertaking economic
evaluations along side clinical trials. It has been argued, when an economi
c evaluation is necessary for assessing the cost-effectiveness of a medical
intervention, the integration of both the medical and clinical issues need
to be included at the start of designing a clinical trial. A proposal has
been made for how clinical researchers and health economists may cooperate
successfully at the successive phases in designing a clinical trial. Theref
ore, discussion points for clinical researchers and health economists are g
iven, and the possible methodological consequences of adding an economic ev
aluation to a trial are addressed.